These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 8041032)

  • 1. Effects of 2,5-hexanedione on rat spinal pyramidal tract.
    Yagi Y
    Sangyo Igaku; 1994 May; 36(3):173-80. PubMed ID: 8041032
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gamma-Diketone central neuropathy: quantitative analyses of cytoskeletal components in myelinated axons of the rat rubrospinal tract.
    Lopachin RM; Jortner BS; Reid ML; Monir A
    Neurotoxicology; 2005 Dec; 26(6):1021-30. PubMed ID: 15964632
    [TBL] [Abstract][Full Text] [Related]  

  • 3. gamma-diketone central neuropathy: quantitative morphometric analysis of axons in rat spinal cord white matter regions and nerve roots.
    LoPachin RM; Jortner BS; Reid ML; Das S
    Toxicol Appl Pharmacol; 2003 Nov; 193(1):29-46. PubMed ID: 14613714
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlated nerve conduction, somatosensory evoked potential and neuropathological studies in clioquinol and 2,5-hexanedione neurotoxicity in the baboon.
    Thomas PK; Bradley DJ; Bradley WA; Degen PH; Krinke G; Muddle J; Schaumburg HH; Skelton-Stroud PN; Thomann P; Tzebelikos E
    J Neurol Sci; 1984 Jun; 64(3):277-95. PubMed ID: 6236287
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Axonal atrophy is a specific component of 2,5-hexanedione peripheral neuropathy.
    Lehning EJ; Dyer KS; Jortner BS; LoPachin RM
    Toxicol Appl Pharmacol; 1995 Nov; 135(1):58-66. PubMed ID: 7482540
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ultrastructural studies of the dying-back process. V. Axonal neurofilaments accumulate at sites of 2,5-hexanedione application: evidence for nerve fibre dysfunction in experimental hexacarbon neuropathy.
    Politis MJ; Pellegrino RG; Spencer PS
    J Neurocytol; 1980 Aug; 9(4):505-16. PubMed ID: 7192310
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative neurotoxicity and pyrrole-forming potential of 2,5-hexanedione and perdeuterio-2,5-hexanedione in the rat.
    DeCaprio AP; Briggs RG; Jackowski SJ; Kim JC
    Toxicol Appl Pharmacol; 1988 Jan; 92(1):75-85. PubMed ID: 3341029
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurotoxic effects of 2,5-hexanedione on growing peripheral nerve axons of rat fetuses.
    Ogawa Y; Komatsu T; Fujikake N; Fujii T; Tanaka J
    Toxicol Lett; 1991 Dec; 59(1-3):59-63. PubMed ID: 1755036
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biophysical and electrophysiological studies of hexanedione neurotoxicity.
    Nachtman JP; Couri D
    Neurotoxicology; 1981 Nov; 2(3):541-56. PubMed ID: 7199690
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of 2,5-hexanedione and acrylamide on myosin heavy chain isoforms of slow and fast skeletal muscles of the rat.
    Oishi Y; Yamamoto H; Nagano M; Miyamoto E; Futatsuka M
    Toxicol Appl Pharmacol; 1996 Jul; 139(1):15-21. PubMed ID: 8685898
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Electrophysiological study of dorsal column function in streptozocin-induced diabetic rats: comparison with 2,5-hexanedione intoxication.
    Terada M; Yasuda H; Kikkawa R; Koyama N; Yokota T; Shigeta Y
    J Neurol Sci; 1993 Mar; 115(1):58-66. PubMed ID: 8468593
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative covalent protein binding of 2,5-hexanedione and 3-acetyl-2,5-hexanedione in the rat.
    DeCaprio AP; Kinney EA; LoPachin RM
    J Toxicol Environ Health A; 2009; 72(14):861-9. PubMed ID: 19557614
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of toxicities of acrylamide and 2,5-hexanedione in hens and rats on 3-week dosing regimens.
    Jortner BS; Ehrich M
    J Toxicol Environ Health; 1993 Aug; 39(4):417-28. PubMed ID: 8345530
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alterations in rat axonal cytoskeletal proteins induced by in vitro and in vivo 2,5-hexanedione exposure.
    DeCaprio AP; O'Neill EA
    Toxicol Appl Pharmacol; 1985 Apr; 78(2):235-47. PubMed ID: 3929425
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Different administration schedules of the same dose of 2,5-hexanedione influence the development of neuropathy and the toxicokinetics.
    Misumi J; Nagano M; Futatsuka M; Zhao W; Kudo M
    Neurochem Res; 1997 Jan; 22(1):27-32. PubMed ID: 9021758
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytoskeletal disorganization induced by local application of beta, beta'-iminodipropionitrile and 2,5-hexanedione.
    Griffin JW; Fahnestock KE; Price DL; Cork LC
    Ann Neurol; 1983 Jul; 14(1):55-61. PubMed ID: 6684411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence that pyrrole formation is a pathogenetic step in gamma-diketone neuropathy.
    Genter MB; Szakál-Quin G; Anderson CW; Anthony DC; Graham DG
    Toxicol Appl Pharmacol; 1987 Feb; 87(2):351-62. PubMed ID: 3103260
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A neurophysiological study on neurotoxicity of 2,5-hexanedione. Auditory brainstem responses in rats].
    Hirata M
    Sangyo Igaku; 1987 Mar; 29(2):145-51. PubMed ID: 3626118
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in the axonal conduction velocity of pyramidal tract neurons in the aged cat.
    Xi MC; Liu RH; Engelhardt JK; Morales FR; Chase MH
    Neuroscience; 1999; 92(1):219-25. PubMed ID: 10392844
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of 2,5-hexanedione on deefferented muscle spindle position sensitivity.
    de Rojas TC; Goldstein BD
    Toxicol Appl Pharmacol; 1990 Apr; 103(2):354-63. PubMed ID: 2139520
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.